Volume 14 - Issue 9 - September 2017

Craig Walker, MD
Clinical Editor
Interventional Cardiologist 
Founder, President, and Medical Director
Cardiovascular Institute of the South
Clinical Professor of Medicine 
Tulane University School of Medicine
Louisiana State University School of Medicine

Vascular Disease Management. 2017;14(9):e198.

Dr Walker presents this month’s case report by Attaran et al, in which iliac vein occlusion was established as the etiology of exertional dyspnea and diminished exercise capacity and where there was symptomatic improvement following iliac venous… | Read More

Robert Attaran, MD;  Sunny Jhamnani MD;  Carlos Mena-Hurtado, MD

Vascular Disease Management. 2017;14(9):e199-e201.

Exertional dyspnea has many causes. We report a case of exertional dyspnea resulting from preload insufficiency due to inadequate venous return. | Read More

Jihad A. Mustapha, MD, Fadi Saab, MD, Kristopher Danielson, DO, Larry J. Diaz-Sandoval, MD, David Bielema, MD, Teresa Hall, DO, Matthew Schuch, MS, Michael Sumners, DO

Vascular Disease Management. 2017;14(9):e202-e207.

Popliteal artery entrapment syndrome (PAES) is a rare condition that occurs primarily in young active patients. We present a case series that highlights the diagnosis of PAES and represents the variability of outcomes based on timing of diagnosis… | Read More

Sushruth Edla, MD and Thomas P. Davis, MD

Vascular Disease Management. 2017;14(9):e208-e209.

The authors offer their perspective on this month’s article on Popliteal Artery Entrapment Syndrome by Mustapha et al. | Read More

Rex Teeslink, MD1 and Saami K. Yazdani, PhD2

Vascular Disease Management. 2017;14(9):e210-e214.

The authors present the Occlusion Perfusion catheter (OPC), a universal drug-delivery device. This catheter allows for delivery of antiproliferative drug to a targeted treatment area, demonstrates exceptional medial layer drug uptake, and can be re-… | Read More

Lowell S. Kabnick, MD, RPhS, FACS, FACPh

Vascular Disease Management. 2017;14(9):e215-e216.

Dr Kabnick presents a clinical update on the VIRTUS trial, which is studying the dedicated venous Veniti Vici stent. | Read More